YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(7)
- Austria(1)
- Belgium(3)
- Canada(53)
- China(20)
- Denmark(2)
- Finland(1)
- France(13)
- Germany(38)
- Greece(2)
- Hong Kong(1)
- Hungary(2)
- India(72)
- Ireland(2)
- Israel(3)
- Italia (5)
- Japan(2)
- Latvia(1)
- Mexico(2)
- New Zealand(1)
- Peru(1)
- Poland(1)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(11)
- Sweden(3)
- Switzerland(23)
- Taiwan(3)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(2)
- Ukraine(1)
- United Kingdom(49)
- United States(646)
- Vietnam(1)
Contract Service Directory
Mogene
Company Headquarters
2252 Welsch Industrial Court
Building A
St. Louis, MO 63146
United States
Contract Service Directory
Related Content
-
Clinical Trials | Drug Development | Logistics | Supply Chain
Reducing the Risk of Comparator Sourcing
Transitioning to a strategic sourcing approach.Contract Pharma 05.26.23
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
New CDMO Vector BioMed Launches Operations
The biomanufacturing company’s mission is to provide access to high-quality lentiviral vectors and address the vector supply bottleneck.02.01.23
-
Breaking News | Facilities | Industry News
Lilly to Invest $450M at Manufacturing Site in Research Triangle Park
Expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products.01.30.23
-
-
-
Breaking News | Clinical Trials
pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.09.22.21
-
Breaking News | Drug Development | Industry News
Veklury Reduced Risk of Hospitalization in High-Risk COVID-19 Patients
Veklury demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19 related hospitalization.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax
Phase 3 ENSEMBLE trial shows booster shot at two months provided 94 percent protection against COVID-19 in the U.S.09.21.21
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Schetter has a proven track record across the entire biopharmaceutical value chain.09.20.21
-
Breaking News | Industry News
Lilly’s Antibody Treatment Gets EUA for Post-Exposure COVID Prevention
Phase 3 study shows bamlanivimab 4200 mg reduced the risk of contracting symptomatic COVID-19 by up to 80 percent in nursing home residents.09.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
BioVaxys Reports Progress on Covid-19 Vax Candidate
Bioproduction partner Wuxi Biologics completes synthesis of recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH programs.09.16.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
Catalent Signs Commercial Supply Agreement with Phathom Pharmaceuticals
Will make lead compound vonoprazan from Winchester, KY facility if approved by FDA.09.16.21
-
Breaking News | Industry News
U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail
Will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022.09.15.21
-
Breaking News | Industry News
U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID
Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.09.15.21
-
-
Breaking News | Industry News | Promotions & Moves
Aurion Biotech Makes Strategic Investments in Manufacturing
Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.09.14.21
-
Drug Development | Laboratory Testing
Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.Garrett Perry, Technical Services Specialists at Teknova 09.14.21
-
Breaking News | Promotions & Moves
-
Biologics, Proteins, Vaccines
COVID Booster Vaccines: What’s Next for FDA
FDA Atty comments on the ongoing vaccine rollout what we can expect for other COVID vaccines in development going forward.09.13.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration
Research collaboration covers multiple antibody research programs.09.10.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
GeneQuine, Exothera Enter Gene Therapy Partnership
To support the next stage of osteoarthritis gene therapy development program.09.10.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Repligen and Navigo Launch Antibody Technology Platform
Introduce industry-first protein A ligand for purification of pH sensitive antibodies.09.10.21
-
Breaking News | Collaborations & Alliances | Drug Development
GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy
GQ-303, the gene therapy candidate, turns joint cells into factories for production of the therapeutic protein proteoglycan 4.09.10.21
-
-
APIs | Drug Development
API Development Trends
Why is it important to consider solid form in API development?John Mykytiuk, Jamie Marshall and Andrew Blythe-Dickens, Sterling Pharma Solutions 09.09.21
-
APIs | Clinical Trial Materials
Outsourcing the Manufacture of Clinical Trial APIs
What to consider when deciding to partner with a CDMO for manufacturing.Josh Hoerner, General Manager, Purisys 09.09.21
-
Drug Delivery
Inhaled Drug Delivery Trends
Designing dry powder devices for inhaled drugs.Andreas M. Meliniotis, Director of Device Development, Vectura 09.09.21
-
A Strong Partnership in Drug Development
How CDMOs and consultants mutually benefit their clients.09.09.21
-
Clinical Trial Materials | Clinical Trials | Supply Chain
Clinical Trial Kitting
Overcome the challenges to make every sample count.Claudia Berrón and Arbi Harootoonian, Avantor 09.09.21
-
Drug Development
Partnering with a CDMO for Orphan Drug Development
Challenges and considerations for advancing rare disease drugs to market.Susan Billings, Vice President & Global Head of Business Development, Curia (formerly known as AMRI) 09.09.21
-
Analytical Services | Bioanalytical Services
Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond
Build resiliency into analytical methods through careful consideration of chromatography partners.Hazel Dickson, PhD, Marketing Manager, Chemistry Group, Waters Corporation 09.09.21
-
Choosing and Managing a CDMO
Speed up your time-to-market, keep development costs under control and smooth the FDA approval and commercial launch process.Dana Toops, President, Avema Pharma Solutions 09.09.21
-
Breaking News | Industry News
Sanofi to Acquire Kadmon in $1.9B Deal
Adds Rezurock, a recently FDA-approved first-in-class treatment for chronic graft-versus-host disease (cGVHD)09.08.21
-
Breaking News | Industry News
Citius Acquires Cancer Drug Asset from Dr. Reddy's
Expands late-stage pipeline with the acquisition of exclusive license rights to E7777, an improved formulation of previously FDA-approved ONTAK.09.08.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Recro and BioCorRx Expand Development and Manufacturing Relationship
Will support BICX104, an implantable naltrexone pellet for the treatment of opioid use disorder.09.08.21
-
Promotions & Moves
Avacta Names Fiona McLaughlin as Therapeutics Division CSO
Dr. McLaughlin is a highly experienced oncology drug developer, bringing over 25 years of experience in research and translational drug development.09.02.21
-
Breaking News | Industry News | Promotions & Moves
Forge Biologics Expands Leadership Team
Announces two key hires in process development and medical affairs.08.30.21
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
ExoCoBio to Build World’s First Clinical Grade Exosome GMP Mfg. Facility
Will invest approximately $20 million to install two types of advanced exosome production lines in Osong South Korea.08.25.21
-
Breaking News | Industry News
J&J Releases COVID-Vax Booster Data
Interim data from these studies demonstrate that a booster dose of the vaccine generated a rapid and robust increase in spike-binding antibodies.08.25.21
-
APIs
Propofol – A Bachem Success Story
The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Regulatory Affairs
FDA Approves Pfizer-BioNTech COVID-19 Vaccine COMIRNATY
Grants first full approval for COVID vaccine.08.23.21
-
Bioanalytical Services
Ensuring Equitable Access to Next-generation Sequencing in Oncology
Recent advances in sequencing techniques have transformed cancer treatment.Gang Song, Ph.D., CEO & Co-Founder, Pillar Biosciences 08.20.21
-
Breaking News | Facilities | Industry News
Xellia’s Cleveland Manufacturing Facility is Commercially Operational
Site producing key anti-infective drug products for U.S. hospitals and patients.08.20.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Beroni Begins Manufacture of Anti-Cancer Drug PENAO
Inks contract manufacturing deal with Aurigene Pharma Services.08.19.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Syngene Expands Biopharma Manufacturing Capacity
Sets up a state-of-the-art microbial facility; expands mammalian facility.08.17.21
-
Breaking News | Industry News | Promotions & Moves
Sharp Names Paul Thomas as Business Development Manager for UK Commercial Services
Thomas has over twenty years’ experience in healthcare and pharma packaging sales.08.13.21
-
Breaking News | Facilities | Industry News | Packaging & Tracking
Comar Cuts Ribbon on New West Coast Facility
The 230,000 square foot facility houses injection molding, injection blow molding and injection stretch blow molding cells.08.13.21
-
Breaking News | Industry News
FDA Amends EUAs for COVID-19 Vaccines
Allows for the use of an additional dose of the Pfizer-BioNTech and Moderna COVID-19 vaccines in certain immunocompromised individuals.08.13.21
-
Bachem Capabilities to Address the New FDA Guideline for Synthetic Peptides
Scientific and regulatory challenges remain a big hurdle on the way to successful approval of generic drugs falling under this guideline.
-
Analytical Services | Biologics, Proteins, Vaccines | Cold Chain Management | GMPs/GCPs | Scale-up/Technology Transfer | Serialization | Solid Dosage/Semi-solids | Vials
CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers
Aphena is a service provider in the pharmaceutical, OTC, medical device, biologics and personal care industries.
-
Breaking News | Industry News
Catalent, Edenbridge Pharma Enter Zydis Formulation Supply Agreement
Novel formulation of glycopyrrolate will use Catalent’s Zydis ODT delivery technology for adjunctive therapy for the treatment of peptic ulcer.08.10.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
BioLife Solutions Acquires Sexton Biotechnologies
Sexton supports cell and gene therapy manufacturing with two product lines; processing and handling solutions, and cell performance supplements.08.09.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture
A Look Into COVID Vaccines, Development and Outsourcing
Fiona Barry of PharmSource discusses COVID vaccines in development and CMO outsourcing trends.08.09.21
-
Breaking News | Collaborations & Alliances | Industry News
Purdue University & US Pharmacopeia Launch Pharmaceutical Industry Technology Forum
The webinar series will focus on the benefits of 3D-Printing pharmaceutical medications.08.05.21
-
Breaking News | Financial Reports
Veklury Drives 2Q Growth for Gilead
Veklury (remdesivir) with sales of $829 million offsets loss of exclusivity of Truvada and Atripla in the U.S. with sales down 72% and 42%, respectively.07.30.21
-
Breaking News | Trials & Filings
Janssen's UPTRAVI IV FDA-Approved for PAH
New therapeutic option allows patients to avoid short-term treatment interruptions and stay on UPTRAVI therapy.07.30.21
-
Financial Reports
J&J's 2Q Pharma Sales Up 17%
STELARA and DARZALEX sales drive growth with sales up 34% to $2.3 billion and up 59% to $1.4 billion in the quarter, respectively.07.29.21
-
Promotions & Moves
ImmunoGenesis Opens Research Lab, Adds Key Roles
To support the expansion of the company's recently licensed key development assets, clinical and business development activities.07.28.21
-
Biologics, Proteins, Vaccines | Drug Development
AAV-Mediated Gene Therapy: Quantifying Viral Titer and Integrity
Droplet Digital PCR offers precise potency data, critical for the proper dosing of gene therapies.Mark White and Marwan Alsarraj , Digital Biology Group at Bio-Rad 07.27.21
-
Breaking News | Trials & Filings
Eisai, Merck’s Drug Combo Approved for Advanced Endometrial Cancer
LENVIMA plus KEYTRUDA demonstrates improvements in overall survival, reducing the risk of death by 32%, and progression-free survival by 40%.07.23.21
-
Breaking News | Industry News
U.S. Govt. Buys Additional 200M Doses of Pfizer-BioNTech COVID Vax
Additional doses will help the U.S. government ensure broad vaccine access into next year.07.23.21
-
Reader Showcase
Aptar CSP’s Activ-Film Technology Protects COVID-19 Tests
Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization from the FDA.07.21.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Filtration & Purification | QA/QC | Reader Showcase
MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development
Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.07.21.21
-
Drug Development | Trials & Filings
AskBio’s Gene Therapy Gets Fast Track
LION-101 is a recombinant adeno-associated virus (rAAV) based vector being developed as a one-time treatment for Limb-Girdle Muscular Dystrophy.07.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Eisai, Biogen’s Lecanemab Gets Breakthrough Designation in AD
Based on pre-specified analysis showing consistent reduction of clinical decline across several clinical and biomarker endpoints at the highest doses.07.20.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.07.20.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Preclinical Outsourcing
Lonza, CN Bio Partner on Prevalidated Hepatocytes for Organ-on-a-chip Range
Lonza will supply cells to be prequalified for use in CN Bio’s innovative PhysioMimix OOC range of Single- and Multi-Organ Microphysiological Systems.07.19.21
-
-
-
-
Breaking News | CRO News | Facilities | Industry News
CRO Charnwood Molecular Expands Capabilities
$75m construction project in Loughborough creates flexible facility for the growing CRO.07.16.21
-
Analytical Services | Supply Chain
Drug Product Safety and Security
Is it even possible in an elongated supply chain?Emil Ciurczak, President, Doramaxx Consulting 07.16.21
-
APIs | Breaking News | cGMP Manufacture | Industry News
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL
License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.07.15.21
-
Breaking News | Collaborations & Alliances
Bicycle Therapeutics, Ionic Pharma Enter License & Collaboration Agreement
Will work together to develop targeted oligonucleotide therapeutics leveraging tissue-targeting TfR1 Bicycle technology.07.13.21
-
Aseptic Processing | Breaking News | Facilities | Fill/Finish | Industry News
SP Doubles Manufacturing Capacity for Fill-Finish and Freeze Dryers
New plant opened for SP i-Dositecno aseptic filling lines equipment and global workforce increased to grow capacity and capabilities.07.12.21
-
Breaking News | Industry News
AMRI Becomes Curia
New brand reinforces ongoing expansion of expertise, capabilities and contributions to health care.07.12.21
-
Aseptic Processing | Breaking News | Fill/Finish | Industry News | Parenterals
Swiss Government Turns to Swissfillon for COVID-19 Test Kit Production
Drug product CMO specialist adapts to provide 0.8 million prefilled syringes.07.08.21
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
LGM Pharma Launches Analytical Services for Drug Developers and Manufacturers
Analytical testing and stability services covers both drug substance and drug product.07.08.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
SRI, Sanofi Enter Drug Discovery Collaboration
Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.07.07.21
-
Facilities | Laboratory Testing | Logistics
A Guide to Outsourced Stability Storage
Watch the on-demand webinar presented by Maureen Gilbert, Site General Manager at Source BioScience.
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
WuXi STA Chooses Middletown Delaware for New Pharma Manufacturing Campus
The CDMO is bringing about 500 jobs to Middletown, with site expected to open in 2024.06.29.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
AskBio’s Gene Therapy Program Gets Fast Track Designation
LION-101 is a recombinant adeno-associated virus based vector being developed as a one-time intravenous infusion for Limb-Girdle Muscular Dystrophy Type 2I/R9.06.28.21
-
Breaking News | Trials & Filings
Roche’s Actemra Receives FDA EUA to Treat COVID-19
Authorization enables emergency use of Actemra in hospitalized adult and pediatric patients.06.28.21
-
Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.
-
Microbiology
On-Demand Webinar: Microbial In-Use Studies
In this webinar, Alcami’s Brent Harlow will guide you through the necessity of these studies and how to successfully perform them for FDA approval.
-
APIs | Drug Development | Formulation Development
QBD Addresses API Supply in Orphan Drug Formulation
Due to the high costs and low demands of the drug product, it is important to efficiently use API supply during the formulation process.
-
Formulation Development
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Breaking News | Collaborations & Alliances | Drug Development
Jacobio Earns $20M AbbVie Milestone
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.06.18.21
-
Breaking News | Facilities | Industry News | Lyophilization
Horizon Therapeutics Buys EirGen Manufacturing Facility
The 44,000 square foot facility in Ireland includes fill-finish and analytical laboratory capabilities with potential for site expansion.06.17.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $425M in Flu Vaccine Manufacturing Facility
Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.06.15.21
-
Hunt for N-Nitrosamines in Medicinal Products
Case studies of analytical testing in the three-step request to review the risk for presence of nitrosamines in medicinal products process issued by EMA/FDA.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.06.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Yposkesi to Build Second Commercial Bioproduction Site
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.06.14.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
Third milestone payment related to the development of Oral KORSUVA.06.11.21
-
Biologics, Proteins, Vaccines | Industry News
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation
Doses to be donated to approximately 100 low- and lower middle-income countries.06.10.21
-
Breaking News | Drug Development
FDA Approves Aducanumab To Treat Alzheimer’s Disease
First novel therapy approved for AD in nearly 20 years was developed by Biogen and its Japanese partner Eisai.Charles Sternberg, Assistant Editor 06.08.21
-
Breaking News | Facilities | Industry News | Inspections
CPL Completes Successful Virtual Health Canada Audit
The CDMO created a virtual tour of its facilities in response to the pandemic.Tim Wright, Editor, Contract Pharma 06.03.21
-
Clinical Trials | Drug Development
The Future is Decentralized: What This Means for Clinical Trial Sites
Benefits for research sites and how to prepare for decentralized trials.Marc Leighton, Vice President of Product at Florence Healthcare 06.02.21
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The modernization of advanced therapy manufacturing.Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
-
Breaking News | Drug Delivery | Facilities | Industry News | Solid Dosage/Creams/Ointments
MedPharm Opens New Manufacturing Facility
State-of-the-art facility in Durham, NC expands the CDMO’s topical and transdermal delivery capabilities.Tim Wright, Editor, Contract Pharma 06.01.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The Modernization of Advanced Therapy ManufacturingDr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21
-
Breaking News | Collaborations & Alliances | Industry News
Hovione and iBET Form Strategic Collaboration
Will combine knowledge from both partners to create innovation in new therapeutic fields.Tim Wright, Editor, Contract Pharma 05.27.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
Gene Therapy Trials
Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21
-
APIs | Cytotoxics and High Potency Manufacturing | Formulation Development | Process Development
Solubility Enhancement of Hydrophobic Drugs and APIs Using Hot Melt Extrusion
Efficient processing and production technology for solid molecular dispersion, HME can provide sustained, modified and targeted drug delivery.Ameya Deshpande, Formulation Scientist, Avomeen 05.25.21
-
Clinical Trials | Drug Development | Information Technology
Clinical Development Trends
Digital modernization, decentralized trials, and advanced therapies drive outsourcing of clinical trials.Kristin Brooks, Managing Editor, Contract Pharma 05.25.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Xeris to Acquire Strongbridge Biopharma
The two businesses will be combined under a new entity called Xeris Biopharma Holdings, specializing in endocrinology and rare diseases.Kristin Brooks 05.24.21
-
Breaking News | Facilities | Industry News | Lyophilization
Argonaut Expands Lyophilization Facility
Enhances manufacturing capabilities with major investment in lyophilization facility expansion.Tim Wright, Editor, Contract Pharma 05.21.21
-
Breaking News | Collaborations & Alliances | Industry News
Zynrelef Anesthetic Receives FDA Approval
Lifecore will manufacture the new innovative drug for treatment of postoperative pain.Charles Sternberg, Assistant Editor 05.17.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Biologics, WuXi STA Establish WuXi XDC JV
To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).Kristin Brooks 05.14.21
-
Breaking News | Promotions & Moves
New Amsterdam Sciences Appoints Executive Vice President
Dr. Christopher van de Wetering brings decades of governmental experience.Charles Sternberg, Assistant Editor 05.12.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Trials & Filings
INOVIO’s DNA COVID Vax Achieves Positive Results
Phase 2 clinical trial shows INO-4800 was generally safe, well-tolerated and immunogenic in all studied age groups.Kristin Brooks 05.10.21
-
APIs | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
FDA Approves ADC Therapeutics' Zynlonta
ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug.Tim Wright, Editor, Contract Pharma 05.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
ADC Therapeutics Receives FDA Approval for Zynlonta
ADC collaborated with Sterling Pharma Solutions to develop Zynlonta.Charles Sternberg, Assistant Editor 05.06.21
-
Are Your Suppliers Supporting Your Growth?
The role of strategic sourcing and procurement for emerging biopharmaceutical companies.Dave Stowe and Jonathan Horn, Tunnell Consulting 05.05.21
-
Bio News | Breaking News | Facilities | Industry News
NuvOx Completes Construction of Expanded Manufacturing Facility
Will manufacture its lead product, NanO2, for clinical trials and commercial supply after FDA approval.Tim Wright, Editor, Contract Pharma 05.03.21
-
Analytical Services | Bioanalytical Services | Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
AMRI Adds R&D and Mfg. Solutions for Orphan Products
Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.Kristin Brooks 04.30.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Launches Research Lentiviral Vector Packaging Service
Enables scientists to package their genetic material of choice to ensure consistent production of functional and intact viruses.Charles Sternberg, Assistant Editor 04.29.21
-
Breaking News | cGMP Manufacture | Industry News
FDA Approves ADMA Biologics Increased IVIG Production
Expanded manufacturing process enables fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin.Kristin Brooks 04.28.21
-
Biologics, Proteins, Vaccines | Breaking News
Introducing ViroCell Biologics
The UK’s first clinical trial focused viral vector manufacturer.Charles Sternberg, Assistant Editor 04.28.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Samsung Biologics, TG Therapeutics Expand Manufacturing Collaboration
Expands existing contract manufacturing deal to further enable global manufacture of ublituximab.Tim Wright, Editor, Contract Pharma 04.27.21
-
Breaking News | Promotions & Moves
GT Biopharma Appoints Gregory Berk CMO
Jeffrey S. Miller, M.D. will become Consulting Chief Scientific Officer, continuing to lead TriKE product candidate clinical trials.Kristin Brooks 04.26.21
-
Breaking News | Industry News
J&J COVID-19 Vaccinations to Resume in U.S.
Recommendation from the U.S. CDC Advisory Committee followed rigorous evaluation of data relating to very rare adverse event involving blood clots.Kristin Brooks 04.23.21
-
Breaking News | Facilities | Industry News | Inspections
Bora Pharmaceuticals Completes Health Canada Inspection
Mississauga site is the company’s first manufacturing facility in North America and is its HQ in the region.Tim Wright, Editor, Contract Pharma 04.23.21
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Nanoform, Aprecia Partner to Advance 3DP Nanomedicines
To explore synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms.Kristin Brooks 04.22.21
-
Breaking News | Drug Development | Drug Discovery
KemPharm Receives $10M Milestone for FDA Approval of Azstarys
Is eligible to receive an additional near-term $10 million milestone payment following DEA scheduling of SDX.Charles Sternberg, Assistant Editor 04.22.21
-
Bio News | Breaking News | Industry News
Frontage Acquires Ocean Ridge Biosciences
Expands genomics services through the acquisition deal.Tim Wright, Editor, Contract Pharma 04.21.21
-
Breaking News | Collaborations & Alliances | Industry News
Kintor, Visum Enter COVID-19 Manufacturing Partnership
To expand proxalutamide manufacturing for treatment of COVID-19 patients.Tim Wright, Editor, Contract Pharma 04.19.21
-
Breaking News | Clinical Trial Materials | Industry News | Promotions & Moves | Solid Dosage/Creams/Ointments
Metrics Names Stephanie Emory Associate Director of Pharma Development
Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.Tim Wright, Editor, Contract Pharma 04.15.21
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
FDA Accepts Airway Therapeutics’ IND for COVID Treatment
To initiate a Phase 1b trial to confirm the feasibility of intratracheal administrations of AT-100 and its beneficial safety and tolerability profile.Kristin Brooks 04.12.21
-
Breaking News | Industry News
Lilly Modifies Purchase Agreement with U.S. for COVID Therapies
Bamlanivimab and etesevimab agreement modified to enable the supply of etesevimab to complement doses of bamlanivimab the U.S. government already purchased.Kristin Brooks 04.12.21
-
Analytical Services | Biologics, Proteins, Vaccines | Drug Development | Microbiology
Vetter Development Service
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval.
-
Aseptic Processing | Fill/Finish | Parenterals | Process Development | Scale-up/Technology Transfer
Vetter Commercial Manufacturing
Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Bora Pharmaceuticals Adds Roller Compaction Capabilities
Installed at Zhunan, Taiwan facility known for manufacturing complex oral solid dose formulations.Tim Wright, Editor, Contract Pharma 04.09.21
-
Breaking News | Clinical Trials | CRO News | Drug Development
Moleculin Selects IQVIA Biotech to Advance COVID Treatment
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Breaking News | Industry News | Information Technology
LabVantage Solutions Expands and Improves its Portfolio
Unveils two new solutions and an updated version of its flagship LIMS platform.Charles Sternberg, Assistant Editor 04.05.21
-
Biologics, Proteins, Vaccines | Regulatory Affairs
What Will Change at FDA for 2021?
(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21
-
Drug Delivery
The Ever-Evolving World of Combination Products
Looking at the benefits and challenges of the trend towards combination products.Ricki A. Chase, M.S, Lachman Consultants 04.01.21
-
Clinical Trials | Drug Development | QA/QC
RBQM Comes of Age: COVID as a Catalyst for Change
Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.Kristin Brooks, Managing Editor 04.01.21
-
Breaking News | Drug Development
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
Expands its oncology leadership capabilities in the U.S.Charles Sternberg, Assistant Editor 04.01.21
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
Breaking News | Industry News | Promotions & Moves
Vibalogics Updates U.S. Leadership Team
Appoints new CFO, VP of quality and head of process sciences.Charles Sternberg, Assistant Editor 03.31.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Facilities | Industry News
Chime Biologics Expands CDMO Capabilities
Completes $190 million financing round to accelerate capacity expansion.Tim Wright, Editor, Contract Pharma 03.29.21
-
Clinical Trials | Drug Development
Regulatory Practices in a Post-Pandemic World
Envisioning the new normal for clinical development.Dr. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 03.22.21
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Gilead, Novo Nordisk Expand NASH Alliance
Phase II trial to investigate Novo’s semaglutide and a combination of Gilead’s cilofexor and firsocostat, alone and in combination in cirrhosis due to NASH.Kristin Brooks 03.18.21
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
Cytocom Gets FDA Clearance for Phase II Trial of COVID Immune Therapy
Phase 2 clinical trial to evaluate the safety and efficacy of CYTO-205 as a treatment to slow or halt the progression of SARS-CoV-2.Kristin Brooks 03.16.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
NJ-based cell and gene therapy development and manufacturing center to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment.Kristin Brooks 03.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioVaxys, Wuxi Biologics Enter Bioproduction Agreement
To synthesize proteins for SARS-CoV-2 vaccine and COVID-T immunodiagnostic programs.Tim Wright, Editor, Contract Pharma 03.15.21
-
Clinical Trials | Information Technology
The Evolution of Clinical Research Technology to Support Remote Collaboration
Pioneering change with technology advancements that yield high reward with tolerable risk.Angela Gill Nelms, COO for Florence Healthcare 03.11.21
-
Breaking News | Capsules | Industry News
CapsCanada Launches Liquid-Filled Hard Capsule Mfg. Service in North America
New service aims to return pharmaceutical and OTC drug manufacturing back to North America.Kristin Brooks 03.10.21
-
Breaking News | Trials & Filings
Lilly's COVID Therapy Boasts Robust New Results
Phase 3 trial data shows bamlanivimab and etesevimab reduces the risk of COVID-related hospitalization and death by 87%.Kristin Brooks 03.10.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact
COVID-19 therapy Bamlanivimab will be manufactured at Jubilant HollisterStier's Spokane, WA facility.03.09.21
-
Breaking News | Industry News
Generic Version of Symbicort Granted FDA Approval
Product is indicated for certain patients with asthma or chronic obstructive pulmonary disease (COPD).Charles Sternberg, Assistant Editor 03.09.21
-
cGMP Manufacture | Process Development | Scale-up/Technology Transfer
Process Intensification: Understanding the Optimal Way to Maximize Productivity
Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21
-
Breaking News | Drug Delivery | Facilities | Industry News | Packaging & Tracking
Vectura Expands Dry Powder Inhaler Capabilities
Bolsters development and manufacturing capabilities at its facility in Chippenham, U.K.Tim Wright, Editor, Contract Pharma 03.09.21
-
Breaking News | cGMP Manufacture | Industry News | Inspections
Metrics Contract Services Completes Russian Regulatory Inspection
Greenville, NC site approved to make an oncology drug to be marketed in Russia.Tim Wright, Editor, Contract Pharma 03.09.21
-
Breaking News | Clinical Trials
Strata Oncology Unveils Strata PATH Trial
The new platform clinical trial will evaluate FDA-approved therapies in novel biomarker profiles learned from real-world data.Charles Sternberg, Assistant Editor 03.02.21
-
Information Technology
5 Reasons Paper Has No Place in Contract Manufacturing
Digital solutions create more efficient manufacturing processes and eliminate delays.Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21
-
Drug Delivery | Parenterals
Injectable Drug Delivery Trends
How medication trends are driving the shift to patient-friendly drug delivery systems.Peter Soelkner, Managing Director, Vetter 03.01.21
-
Cold Chain Management | Logistics | Packaging & Tracking | Supply Chain
Reshaping the Pharmaceutical Supply Chain
The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.Kristin Brooks, Managing Editor 03.01.21
-
Breaking News | Industry News
J&J’s Single-Dose COVID-19 Vax Issued EUA
Phase 3 ENSEMBLE study demonstrated the vaccine was 85 percent effective in preventing severe disease.Kristin Brooks 03.01.21
-
Breaking News | Collaborations & Alliances | Industry News
Phlow Corp. and USP Form Alliance
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Industry News
Thermo Fisher Scientific Completes Mesa Biotech Acquisition
Becomes part of the Life Sciences Solution Segment and is expected to add revenue of approximately $200 million in 2021.Kristin Brooks 02.26.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 02.25.21
-
Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing
Altasciences Contributes to Vibegron Approval
Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.Kristin Brooks 02.24.21
-
Breaking News | Drug Development | Industry News
Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
Sentynl acquires CUTX-101 Copper Histidinate for the treatment of Menkes disease for $20 million in upfront and regulatory milestones.Kristin Brooks 02.24.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Pfizer Selects Seven Bridges to Support RNA Sequencing Data
Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.Kristin Brooks 02.24.21
-
Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
Glatt and Aprecia Enter 3D-Printing Collaboration
Aprecia's compression-free 3DP manufacturing platform expands Glatt capabilities in innovative particle design.Tim Wright, Editor, Contract Pharma 02.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Kaneka Eurogentec Expands Capabilities
Receives GMP accreditation for new mRNA manufacturing facility, COVID-19 vaccine production ongoing.Tim Wright, Editor, Contract Pharma 02.17.21
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
Molecular Templates, BMS Enter Strategic Research Pact
Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.Kristin Brooks 02.11.21
-
Breaking News | Facilities | Industry News
Scapa Healthcare Enhances OTC Drug Manufacturing Capabilities
Makes multimillion dollar investment at its Knoxville facility.Tim Wright, Editor, Contract Pharma 02.10.21
-
Biologics, Proteins, Vaccines | Breaking News
RotaChrom Technologies Partners with Cyclolab
Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.Charles Sternberg, Assistant Editor 02.09.21
-
Trials & Filings
FDA Approves BMS CAR-T Cell Therapy
Breyanzi is a CD19-directed chimeric antigen receptor (CAR) T cell therapy for the treatment of relapsed or refractory large B-cell lymphoma.Kristin Brooks 02.08.21
-
Breaking News | Industry News | Promotions & Moves
AMRI Makes Executive Move
Appoints Scott Waldman to lead corporate development.Tim Wright, Editor, Contract Pharma 02.08.21
-
Breaking News | Facilities | Fill/Finish | Industry News | Lyophilization | Parenterals
Argonaut Opens Custom Controls and Standards Facility
Formulation and filling will be performed at a state-of-the-art site in Carlsbad, CA.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Paragon Biosciences Expands Cell and Gene Therapy Platform
Launches CiRC Biosciences with an initial focus on developing eye disease treatments.Tim Wright, Editor, Contract Pharma 02.08.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Inside a COVID Vaccine Trial
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.Kristin Brooks, Managing Editor 02.05.21
-
Breaking News | Financial Reports
Financial Report: Lilly
Recognizes worldwide revenue of $871.2 million in the quarter for bamlanivimab COVID-19 treatment.Kristin Brooks 02.05.21
-
Breaking News | Financial Reports
Regeneron 4Q and FY20 Results
REGEN-COV antibody cocktail for COVID-19 received FDA EUA; Net sales of REGEN-COV were $146 million in the quarter and $186 million for the year.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate
Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.Kristin Brooks 02.05.21
-
Cold Chain Management | Logistics | Supply Chain
Delivering Custom Client Solutions
Cold chain solutions provider Sentry BioPharma Services is able to adapt to meet the diverse needs of its clients.Contract Pharma Staff
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Evozyne, Takeda Ink Strategic Protein Design Agreement
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.Kristin Brooks 01.27.21
-
Clinical Trials | Information Technology
The State of Clinical Trial Technology
Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.Kristin Brooks, Contract Pharma 01.26.21
-
Breaking News | Formulation Development | Industry News | Methods Development
Adare Pharma Solutions Opens New Small-Scale Lab
Vandalia, OH lab offers customizable, flexible systems designed to expedite formulation and process development services.Kristin Brooks 01.26.21
-
Breaking News | Capsules | Cold Chain Management | Fill/Finish | Industry News | Solid Dosage/Semi-solids
Aphena’s $21M Cookeville Expansion Nears Completion
Bottle packaging capacity has been expanded with the installation of 10 high-speed bottling lines to start.Kristin Brooks 01.26.21
-
Breaking News
500+ Sites Join Inato’s Industry Marketplace
Platform aims to make clinical research more inclusive and efficient.Charles Sternberg, Assistant Editor 01.26.21
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
Will produce sterile injectable meds used in hospitals for COVID-19 patient care.Tim Wright, Editor, Contract Pharma 01.25.21
-
Breaking News | Industry News
Pfizer, BioNTech Enter Vax Pact with COVAX
Initial agreement provides up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine to COVAX in 2021, with first deliveries expected in 1Q21.Kristin Brooks 01.22.21
-
Breaking News | Trials & Filings
FDA Approves Janssen’s CABENUVA
Becomes first and only once-monthly, long-acting regimen for the treatment of HIV infection.Kristin Brooks 01.22.21
-
Breaking News | Promotions & Moves
Eisai Appoints Chief Clinical Officer of Oncology Biz
Dr. Richard Woodman has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations.Contract Pharma Staff 01.20.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
JS Bio and Etta Biotech Advancing Partnership
Will set up a high titer transient protein expression platform for high quality protein production.Contract Pharma Staff 01.19.21
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Precision Medicine Group Acquires Project Farma
Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.Contract Pharma Staff 01.14.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
iosBio Inks Exclusive Vax Platform Pact for COVID-19
OraPro oral delivery vaccine platform technology enables oral administration of thermally-stable, viral vector vaccines.Contract Pharma Staff 01.12.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Parenterals
Irisys Receives NIH Contract for the Formulation of Drinabant
Seeks to develop a drug for treatment of acute cannabinoid overdose.Contract Pharma Staff 01.11.21
-
The Changing R&D Landscape
Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
MilliporeSigma Acquires AmpTec
Expands mRNA capabilities for vaccines, treatments and diagnostics.Contract Pharma Staff 01.07.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Breaking News | Clinical Trials | Promotions & Moves
Parexel Appoints Chief Patient Officer
Demonstrates the company’s commitment to elevating the patient perspective.Contract Pharma Staff 01.06.21
-
Breaking News | Collaborations & Alliances | Industry News
Angelini Pharma Acquires Arvelle Therapeutics for $960M
Angelini to become a leader in CNS and mental health disorder treatments; opening direct affiliates in France, UK, Nordics and Switzerland by 2022.Contract Pharma Staff 01.05.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
Analytical Services | Biologics, Proteins, Vaccines | Clinical Trial Materials | Laboratory Testing
Samsung Biologics Continues to Leverage Digitalization to Optimize Client Experience
Through digital transformation, Samsung Biologics is innovating how they connect with clients, regulatory bodies and industry professionals.
-
Breaking News | Industry News | Trials & Filings
Moderna Wins FDA Authorization for COVID-19 Vax
The primary efficacy analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1%.Contract Pharma Staff 12.21.20
-
Breaking News | Packaging & Tracking
Aptar CSP Increases Capacity for Active Packaging Solutions
3-Phase Activ-Polymer platform technology protects electrochemical, lateral flow, and molecular diagnostic test kits.Contract Pharma Staff 12.17.20
-
APIs | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Aurinia and Lonza Expand Manufacturing Partnership
Form agreement for voclosporin manufacturing capacity.Contract Pharma Staff 12.16.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Kristin Brooks, Contract Pharma 12.14.20
-
Drug Development
Navigating Uncertainty: Considerations for Life Sciences 2021
With vaccines against COVID-19 on the horizon, our focus is shifting to 2021 and the major issues life sciences companies face and reasons for optimism.Arda Ural , EY Americas Health Sciences and Wellness Industry Leader, Ernst & Young LLP 12.11.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
Ascentage Selects PharmaBlock as Preferred Provider
PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.Contract Pharma Staff 12.11.20
-
Breaking News | Industry News
Gilead to Acquire MYR GmbH for €1.15B
Gains Hepcludex, a first-in-class treatment for HDV; anticipates accelerated global launch as a result of the acquisition.Contract Pharma Staff 12.10.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Parenterals
Thermo Fisher Scientific Further Expands Global Footprint
Will expand sites in Greenville, NC; Swindon, UK; and Ferentino and Monza, Italy for sterile drug product development and commercial manufacturing.Contract Pharma Staff 12.10.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
atbtherapeutics, iBio CDMO Enter Manufacturing Agreement
Will work together for the industrialization of the GMP manufacturing process of atbtherapeutics’ atbodies.Contract Pharma Staff 12.09.20
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Sesen Bio Enters Mfg. and Supply Partnership with Qilu Pharma
Technology transfer to Qilu anticipated to be completed in mid-2021.Contract Pharma Staff 12.09.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19
The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.Contract Pharma Staff 12.04.20
-
Pfizer, BioNTech Submit CMA for Covid-19 Vax to EMA
Approval could potentially enable the use of BNT162b2 in Europe before the end of 2020.Contract Pharma Staff 12.01.20
-
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Syngene and 3DC Sign 5-year Collaboration
Partner on discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.Contract Pharma Staff 11.24.20
-
Drug Delivery | Drug Development
Inhaled Drug Delivery Technology Trends
The success of new inhaled medicines relies on the correct combination of formulation and device technology.Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
-
Breaking News | cGMP Manufacture | Industry News
Catalent, Blueprint Enter GAVRETO Commercial Supply Pact
Following FDA approval and tech transfer, the Catalent team in Kansas City will support commercial supply of the non-small cell lung cancer drug.Contract Pharma Staff 11.23.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ARCA Biopharma’s AB201 for COVID-19 Gets Fast Track
Initiation of ASPEN-COVID-19 Phase 2b clinical trial anticipated in December with trial data anticipated 2Q21.Contract Pharma Staff 11.23.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.Contract Pharma Staff 11.20.20
-
Breaking News | Industry News | Information Technology | Promotions & Moves
Sharp Implements Cloud-Based QMS
Strengthens quality leadership with new appointments.Contract Pharma Staff 11.18.20
-
Trials & Filings
Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
Meets all primary efficacy endpoints, demonstrates BNT162b2 to be 95% effective against COVID-19.Contract Pharma Staff 11.18.20
-
APIs | Breaking News | Industry News
Almac Gets Grant From COVID-19 Therapeutics Accelerator
Will work to enable efficient manufacturing of remdesivir in Response to COVID-19.Contract Pharma Staff 11.18.20
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
Injectables Firms Expand Capacity
CDMOs see steriles demand grow.S. Harachand, Contributing Editor 11.17.20
-
Excipients
Bye-Bye China?
Instead of closing its doors on China, Western pharma industry needs to take a balanced approach and perform proper due diligence based on objective criteria.Michele Jermini and Enrico Polastro 11.17.20
-
Clinical Trials | Information Technology | R&D
Decentralized Trials Fuel AI Revolution in Clinical Research
The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20
-
Scale-up/Technology Transfer
Ensuring Quality During the Transfer and Scale Up of Rx Drugs
Defining the key parameters and considerations for a successful technology transfer.Tom Chang, President, Bora Pharmaceutical Laboratory Co. Ltd. 11.17.20
-
Breaking News | Collaborations & Alliances | CRO News
PathoQuest, Charles River Expand Strategic Pact
Establishes a biologics genomic testing laboratory in Wayne, PA to expand next-generation sequencing capabilities.Contract Pharma Staff 11.12.20
-
Financial Reports
Financial Report: Merck
Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.Contract Pharma Staff 11.04.20
-
Breaking News | Financial Reports
Financial Report: Gilead
Veklury (remdesivir) revenues were $873 million in the third quarter.Contract Pharma Staff 10.28.20
-
Breaking News | Drug Development | Trials & Filings
Gilead’s Remdesivir Wins FDA Approval to Treat COVID-19
Veklury is now the first and only approved COVID-19 treatment in the U.S.Contract Pharma Staff 10.23.20
-
Biologics, Proteins, Vaccines | Breaking News
FDA Issues Guidance on EUA for COVID-19 Vaccines
Provides further information on the EUA process for investigational vaccines.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
FibroGenesis Collaborates with R4D Biotech
Expands the fight against COVID-19 in Brazil.Contract Pharma Staff 10.02.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
FDA Clears IND Application for Vaxart Oral COVID-19 Vaccine
Recruitment for the Phase 1 clinical study is expected to start this month.Contract Pharma Staff 09.16.20
-
Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
Expediting a COVID-19 Vaccine: FDA Approval Process
The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.Kristin Brooks, Managing Editor 09.09.20
-
Clinical Trials | Drug Development
FDA Response to COVID-19
A Discussion on Protocol Amendments and Clinical Study Reports in Affected Ongoing Trials.Jack Modell, M.D., Vice President and Senior Medical Officer, Rho 09.03.20
-
Breaking News | Trials & Filings
FDA Clears SPI’s Ebselen for Phase II COVID-19 Trials
SPI-1005 is a novel anti-inflammatory drug which was recently shown to inhibit nCoV2 activity and viral replication.Contract Pharma Staff 08.31.20
-
Biologics, Proteins, Vaccines | Drug Development | Regulatory Affairs
Expediting a COVID-19 Vaccine: FDA Approval Process
The pressures of the pandemic are pushing sponsors and FDA to look at both efficacy and speed in developing a vaccine.Kristin Brooks, Contract Pharma 08.25.20
-
Breaking News | Facilities | Industry News | Inspections
FDA Approves Romark Facility in Puerto Rico
The facility is equipped to produce tablets, powders and other oral solid dosage forms.Contract Pharma Staff 08.24.20
-
Breaking News | Trials & Filings
FDA Approves Roche’s Tecentriq Combo for Melanoma
Tecentriq with Cotellic and Zelboraf helped people live longer without disease worsening or death compared to placebo.Contract Pharma Staff 07.31.20
-
Breaking News | cGMP Manufacture | Laboratory Testing
Alcami Site Expansion Nears Completion
GMP Laboratory testing will begin this month.Contract Pharma Staff 07.31.20
-
APIs | Breaking News | Industry News
ChemWerth Files its 500th Drug Master File with FDA
API supplier supports both large and small finished dosage companies worldwide.Contract Pharma Staff 07.23.20
-
Breaking News | Collaborations & Alliances | Industry News
Patheon to Manufacture FDA-Approved Nasal Spray
Evoke Pharma initiates commercial manufacturing of Gimoti with the CDMO.Contract Pharma Staff 07.17.20
-
Breaking News | Collaborations & Alliances | Industry News
Moleculin Enters Agreement with Sterling Pharma
Will produce WP1122 for potential treatment of COVID-19.Contract Pharma Staff 07.15.20
-
Drug Development | Trials & Filings
FDA Approves Expanded Use for BOTOX
For the treatment of spasticity in pediatric patients 2 years of age and older, including those with lower limb spasticity caused by cerebral palsy.Contract Pharma Staff 07.10.20
-
Pii Gets Registered as a Part of the FDA’s 503B Solution
Added to the list of organizations officially registered as human drug outsourcing facilities.Contract Pharma Staff 07.06.20
-
Breaking News | Industry News
ADMA Biologics Opens New Plasma Collection Facility
Aims to open 5 to 10 more collection centers by the end of 2022.Contract Pharma Staff 07.06.20
-
EMD Serono, Pfizer Win FDA Approval for sBLA for BAVENCIO
For the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma.Contract Pharma Staff 07.01.20
-
Breaking News | Industry News
FDA Issues EUA to HymonSARS-CoV-2 Test Kit for Detection of COVID-19
SpectronRx and HymonBio expect to produce 10 million tests per month for labs around the world.Contract Pharma Staff 06.18.20
-
Breaking News
Lupin Pharmaceuticals Recalls One Lot of Metformin Hydrochloride Extended-Release Tablets
The product was found to more than the acceptable amount of NDMA, a carcinogen.Contract Pharma Staff 06.11.20
-
Breaking News | Drug Development
FDA Grants Orphan Drug Designation for Brain Cancer Drug Berubicin
Accelerates its development to treat malignant gliomas and provides CNS with the potential for market exclusivity.Contract Pharma Staff 06.11.20
-
Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Aspargo Laboratories Completes Pre-IND Meeting with FDA
Collaborating with the CDMO Pii to develop and manufacture Sildenafil Oral Spray for clinical trialsContract Pharma Staff 06.08.20
-
Aetion Launches Research Collaboration with FDA
Aims to advance understanding of COVID-19.Contract Pharma Staff 05.20.20
-
Virpax Completes Pre-IND Meeting with FDA on Epoladerm
To pursue a 505(b)(2) New Drug Application for Epoladerm in osteoarthritis of the knee.Contract Pharma Staff 05.20.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
bluebird bio Amends CAR-T Collaboration
Bristol Myers Squibb assumes responsibility for vector manufacturing in ex-U.S. territoriesContract Pharma Staff 05.18.20
-
Breaking News | Facilities | Industry News | Inspections
PharmaCyte Conducts Final Audit of Mfg. Facility
Batch records in Thailand have been deemed cGMP compliantContract Pharma Staff 05.18.20
-
Breaking News | Industry News | Laboratory Testing
Thermo Fisher Gets Expanded EUA for SARS‑CoV‑2 Test
This third expansion further increases the number of high-throughput PCR instruments that labs can use to run tests.Contract Pharma Staff 05.13.20
-
Breaking News | Collaborations & Alliances | Industry News
Sorrento, Mount Sinai to Develop COVI-Shield Antibody Therapy
Targets SARS-CoV-2 infection (COVID-19) with an antibody cocktailContract Pharma Staff 05.12.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
HJB, Mabspace Ink Development and Manufacturing Agreement
Program aims to bring more efficacious treatment options to cancer patientsContract Pharma Staff 05.12.20
-
Breaking News | Industry News
FDA COVID-19 Update
Authorizes the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testingContract Pharma Staff 05.11.20
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Catalent Provides Clinical Support for COVID-19 Study
Partners with Humanigen for FDA-approved Phase 3 lenzilumab study for COVID-19 patientsContract Pharma Staff 05.08.20
-
Analytical Services | Breaking News | Risk Management
CluePoints Tech Benefits Clinical Studies Affected by COVID-19
Its COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies.Contact Pharma Staff 05.07.20
-
Breaking News | Collaborations & Alliances | Industry News | Information Technology
Quartic.ai Partners with Bright Path Labs
Collaborate to develop AI-powered continuous manufacturing of critical APIs for medicinesContract Pharma Staff 05.06.20
-
Breaking News | Collaborations & Alliances | Industry News
BARDA Funds Development of Tangen Biosciences’ Multi-Target Platform
Also awards Tangen a new contract for Point-of-Care COVID-19 molecular testContract Pharma Staff 05.06.20
-
Breaking News | Collaborations & Alliances | Industry News
AGC Biologics Inks Manufacturing Deal with Faron
The CDMO will manufacture novel precision cancer immunotherapy treatment ClevegenContract Pharma Staff 05.06.20
-
Speeding Vaccine Development with Advanced Analytics
Having immediate access to wide ranging resources of data can help speed the COVID-19 vaccine development processDr. Shlomi Madar, VP of Healthcare Solutions, Signals Analytics 05.05.20
-
HCQ Comes Center Stage
Indian players ramp up chloroquine productionS. Harachand, Contributing Editor 05.05.20
-
Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Aji Bio-Pharma, CytoDyn Enter COVID-19 Mfg. Pact
Aji Bio-Pharma provides drug product aseptic fill finish services for CytoDyn's Leronlimab, currently being used in clinical trials for COVID-19 patientsContract Pharma Staff 05.05.20
-
Breaking News | Industry News
AMRI Increases HCQ Production in U.S.
Ready to meet potential COVID-19 demandContract Pharma Staff 05.04.20
-
Breaking News | Industry News
Gilead Granted EUA for Remdesivir in COVID-19
Facilitates broader use of remdesivir to treat hospitalized patients with severe COVID-19 diseaseContract Pharma Staff 05.01.20
-
Industry News | Regulatory Affairs
FDA COVID-19 Update
Issues guidance highlighting flexibility under the Drug Supply Chain Security ActContract Pharma Staff 05.01.20
-
cGMP Manufacture | Drug Development
Accelerating Life-Saving Drugs to Market During COVID-19 Pandemic
Streamlining drug development with CDMOsMasha Kononov, Senior Director Emerging Pharma, USA, Arcinova, and Stephen Brown, Pharmaceutical and Biotech Consultant 05.01.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Scale-up/Technology Transfer
Moderna, Lonza Enter COVID-19 Vaccine Mfg. Pact
Aims to enable manufacturing of up to 1 billion doses per year with first batches of mRNA-1273 expected to be manufactured at Lonza U.S. in July 2020Contract Pharma Staff 05.01.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Valneva Collaborates with Pfizer On Lyme Disease Vaccine
VLA15 is being evaluated for adult and pediatric indications in North America and EuropeContract Pharma Staff 04.30.20
-
Breaking News | Drug Development | Industry News
Supernus Acquires US WorldMeds’ CNS Portfolio
Adds three marketed products in the U.S. and a product candidate in late-stage development.Contract Pharma Staff 04.29.20
-
Breaking News | Industry News
Genalyte Launches High-Speed COVID-19 Antibody Test
First instrument-based, rapid test uses multi-antigen approach; U.S. FDA EUA submittedContract Pharma Staff 04.28.20
-
Breaking News | Industry News
FDA COVID-19 Update
FDA issues a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquineContract Pharma Staff 04.27.20
-
APIs | Breaking News | Industry News | Supply Chain
FDA Releases Coronavirus Supply Chain Update
Manufacturer alerts FDA to a shortage of a drug related to site affected by coronavirus03.02.20
-
Breaking News | Industry News | Inspections | QA/QC | Regulatory Affairs
FDA Provides Update on Activities Related to Coronavirus
Says it continues to monitor the global drug supply chain by prioritizing risk-based inspections in other parts of the world02.25.20
-
Drug Development
Major Drug Approvals of 2019
Abbvie, Novartis, Pfizer and J&J score big wins with blockbuster potentialKristin Brooks, Contract Pharma 02.24.20
-
-
Breaking News | Clinical Trials | CRO News | Drug Development | Regulatory Affairs
Parexel Launches Regulatory & Access Consulting Organization
Alignment of these capabilities aims to save time and resources across the drug development lifecycle01.10.20
-
Breaking News | Drug Development | Industry News
Lilly to Acquire Dermira
Expands Lilly's immunology pipeline with the addition of lebrikizumab, a Phase III monoclonal antibody to treat atopic dermatitis01.10.20
-
APIs | Breaking News | cGMP Manufacture | CRO News | Drug Development | Facilities | Industry News
Alcami Sells Netherlands Site to MerachemSyncom
Expands portfolio of chemistry services from compound design to clinical proof of concept.01.09.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Injectables | Parenterals
Hikma and Arecor Enter Injectables Alliance
Form agreement to develop and commercialize ready-to-use medicine using Arestat technology.01.09.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
ADMA Biologics Enters Mfg. and Supply Agreement
To produce and sell plasma-derived intermediate fractions.01.07.20
-
Breaking News | Promotions & Moves
CARsgen Therapeutics Appoints Global Regulatory Affairs SVP
Dr. Fan will be responsible for CARsgen global regulatory strategy, leading the U.S. and China regulatory affairs team01.06.20
-
Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
Janssen, PRA Design First Mobile Virtual Trial
Kent Thoelke and Greg Licholai of PRA discuss the alliance, advances that have made virtual clinical trials possible, and the obstacles that remainKristin Brooks, Contract Pharma 01.06.20
-
APIs | Breaking News | Facilities | Industry News
WuXi STA Opens Large-Scale Oligonucleotide Mfg. Facility
State-of-the-art facility expands capacity and capability for this novel modality, providing services from preclinical to commercial.01.03.20
-
Breaking News | Drug Development | Trials & Filings
FDA Approves Allergan’s UBRELVY
Represents the first and only orally-administered CGRP receptor antagonist for the treatment of migraine01.02.20
-
Breaking News | cGMP Manufacture | Chemistry | Industry News
OncoImmune’s IND Gains FDA Clearance
WuXi Biologics to provide CMC development and GMP manufacturing of the drug substance and drug product for next-gen anti-CTLA-4 antibody01.02.20
-
Drug Development | R&D
Top Pharma M&A Deals of 2019
Drug manufacturers spent a record $342 billion on Mergers & AcquisitionsKristin Brooks, Contract Pharma 12.23.19
-
MAY THE FLOW BE WITH YOU: CONTINUOUS FLOW MANUFACTURING OF PHARMACEUTICAL INGREDIENTS
A clear increase in continuous flow processes has emerged over the past decade.
-
Trials & Filings
XTANDI Approved for mCSPC
The first oral treatment in three distinct types of advanced prostate cancer –non-metastatic and metastatic castration-resistant prostate cancer (CRPC).Astellas 12.17.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
U.S.-based, state-of-the-art facilities to be established for sustainable production of adjuvanted recombinant vaccine for use in the event of a pandemic.Sanofi 12.13.19
-
-
Breaking News | CRO News | Promotions & Moves
Parexel Adds Experts to Regulatory Consulting Group
Four new hires from U.S. FDA and MHRA will serve as technical vice presidents12.10.19
-
Breaking News | Formulation Development | Industry News
Catalent, Bridge Therapeutics Execute Exclusive License Agreement
To utilize Catalent’s Zydis orally disintegrating tablet (ODT) technology for opioid addiction therapeutic product12.10.19
-
Breaking News | Drug Development | Trials & Filings
VistaGen Gains Fast Track for SAD Drug
PH94B neuroactive nasal spray for on-demand treatment of social anxiety disorder completes successful Phase II development12.10.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Pasteur Awarded HHS Pandemic Flu Vax Contract
To increase domestic pandemic influenza vaccine production capabilities in Swiftwater, PA12.09.19
-
CRO News
Vivera Pharma, Parexel Ink Clinical Services Agreement
Parexel to conduct Phase I study to evaluate the bioavailability of TABMELT technology and provide regulatory support for Vivera's IND12.06.19
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Recipharm, RedHill Biopharma Ink Commercial Mfg. Pact
CDMO to provide commercial manufacturing to support Talicia launch following FDA approval.12.04.19
-
Breaking News | Formulation Development | Industry News
Catalent, Ethicann Partner on Fast-Dissolve Treatment
Will leverage Catalent’s Zydis ODT technology to develop a new pharmaceutical-grade CBD and THC product to treat spasticity in MS patients12.03.19
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Piramal, BerGenBio Partner on Leukemia Drug
Piramal to leverage its Xcelerate Integrated Solutions platform and is expected to provide commercial manufacturing of the final product12.03.19
-
Breaking News | Collaborations & Alliances
Appili, Saptalis Enter Commercial Pact
Saptalis to oversee the regulatory review, manufacturing and preparation for the anticipated commercialization of ATI-1501 in the U.S.12.03.19
-
Biologics, Proteins, Vaccines | Drug Development
Immunogenicity Assessment of Gene Therapy Compounds
Dr. Kromminga of BioAgilytix discusses testing challenges and evolving trends in gene therapy.Dr. Arno Kromminga, global chief scientific officer, BioAgilytix 11.27.19
-
Breaking News | Collaborations & Alliances | Industry News | Supply Chain
Vizient and Fresenius Kabi Expand Partnership
Complete Novaplus contract enhancement for six critical care drugs.11.26.19
-
Breaking News | Drug Development | Trials & Filings
SK Bio Gains FDA Approval for XCOPRI
Marks the first time a Korean company has independently brought a compound from discovery to U.S. FDA approval11.25.19
-
Breaking News | Collaborations & Alliances | Drug Development | Trials & Filings
Roche’s Risdiplam for SMA Granted Priority Review
FDA filing triggers $15M milestone to development partner PTC Therapeutics11.25.19
-
Cold Chain Management | Logistics | Serialization | Supply Chain
Review of FDA DSCSA Guidance Documents
Brian Daleiden of TraceLink reviews the latest requirements from the FDA and DSCSA
-
Supply Chain
Effect of Personalized Medicine on the Pharma Supply Chain
As the FDA approves personalized drugs, the pharmaceutical supply chain must transform to meet the demand.Alexander Amelin, SVP, client success, SoftServe 11.22.19
-
Assessing Current DSCSA Implementation
A detailed view of the industry’s progress with DSCSA Serialization Requirements.Peter Sturtevant, Senior Director Industry Development - Pharmaceuticals, GS1 US 11.22.19
-
Breaking News | cGMP Manufacture | Industry News
Catalent, BeiGene Enter Long-Term Supply Agreement
Will manufacture BRUKINSA, a Bruton’s tyrosine kinase (BTK) inhibitor that recently received accelerated approval from the U.S. FDA.11.21.19
-
Breaking News | cGMP Manufacture | Industry News
IsoTherapeutics Gains Approval to Manufacture Q BioMed Drug
ITG is now cleared to manufacture the company's FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP11.21.19
-
Injectables
Pitfalls to Avoid When Packaging Injectable Drug Products
Addressing legacy systems, lack of innovation adoption, and special challenges of New Molecular Entities.Fran DeGrazio, VP, Scientific Affairs and Technical Services, West Pharmaceutical Services 11.20.19
-
APIs
India to Track API Packs
India is mulling a shakeup in the regulations governing the distribution of pharmaceutical products.S. Harachand, Contributing Editor 11.20.19
-
Solid Dosage/Creams/Ointments
The “Greening” of Solid Dosage Form Manufacturing
Going “green” can mean saving big bucks for pharma manufacturers.Emil W. Ciurczak, DoraMaxx Consulting 11.20.19
-
When Life Gives You Lemons…Raise Your Drug Prices
The hidden effect of economic models on global drug supply and shortages.Ben Locwin 11.20.19
-
A Pharmaceutical Smörgåsbord
This last issue of the year covers a wide range of pharma topics.Tim Wright, Editor 11.20.19
-
Supply Chain
Clinical Trial Technology
The use of new technology to monitor and manage clinical trialsRicky Lakhani, Director of Product Management, PHARMASEAL 11.20.19
-
Biologics, Proteins, Vaccines
Regenerative Medicine: Overcoming the supply chain challenges
Accomplishing the goal of widespread use of regenerative medicine doesn’t come without its challenges.Rich Quelch, Global Head of Marketing, Origin 11.20.19
-
Excipients
Towards Sunset or a New Dawn?
China as the world production hub of fine and specialty chemicals.Dr. Michele Jermini and Dr. Enrico Polastro 11.20.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Toxicology
WuXi AppTec’s Lab Testing Division Expands in Suzhou
Increases toxicology capacity by 80% to execute full-service preclinical and clinical safety assessments for biologics and small molecules11.19.19
-
Breaking News | Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
Frontage Implements ClinSpark eSource Platform
Web-based eSource platform supports activities from subject recruitment through database lock11.19.19
-
Biologics, Proteins, Vaccines | Clinical Trials
Advanced Therapies: Adding a New Layer of Complexity to Clinical Trials
Overcoming the challenges of a new and changing clinical trial landscapeErin Finot, Global Head of Immuno-Oncology, IQVIA Biotech 11.18.19
-
Breaking News | Facilities | Industry News | Inspections
Metrics Completes Japanese Regulatory Inspection
Marks the first international inspection of the company’s new 126,000-square-foot commercial manufacturing facility constructed in 2018.11.18.19
-
Drug Development | Industry News
Roche to Acquire Promedior in $1.4B Transaction
Gains full rights to Promedior's entire portfolio of molecules for serious fibrotic diseases11.15.19
-
CDMOs to Benefit From Rising BTDs, Orphan Drugs and Fast Track Status
The arrival of patient-centric CDMO’s predicted by CPhI Annual Report.11.14.19
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News | Packaging & Tracking
Stevanato, Duoject Enter Auto-injector Collaboration
Partnership to promote and manufacture the emergency-use ‘Maverick’ auto-injector.11.13.19
-
Biologics, Proteins, Vaccines
Cell and Gene Therapy Landscape
Heather Myler of PPD provides current insight into the growing field of Cell and Gene Therapies11.12.19
-
Drug Development | Industry News
-
Analytical Services | Bioanalytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Formulation Development
Contract Pharma’s 20th Anniversary Series: Ajinomoto Bio-Pharma
David Enloe of Ajinomoto Bio-Pharma Services shares his perspective on market changes over the years and the evolution of more integrated outsourcingKristin Brooks, Contract Pharma 11.11.19
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
PharmaCyte Biotech Closer to Submitting IND
Austrianova completes encapsulation of second manufacturing run of clinical trial product.11.11.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
IDT Biologika, NIH Mfg. Contract Updated
Awarded new task order in the scope of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases.11.11.19
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Bryn Partners With Aptar for Nasal Spray Device
Bryn’s Epinephrine Nasal Spray has two doses in one portable device.11.01.19
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
-
Breaking News | Industry News | Regulatory Affairs | Solid Dosage/Creams/Ointments
Absorption Systems Awarded Contract by FDA
To conduct in vitro testing of the effects of excipients on oral drug absorption.11.01.19
-
cGMP Manufacture | Drug Development
Contract Pharma’s 20th Anniversary Series: CDMO Insight
JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.Kristin Brooks, Contract Pharma 11.01.19
-
Breaking News | Industry News | Regulatory Affairs
FDA Leaders Address Drug Shortages
Acting Commish Ned Sharpless and CDER director Janet Woodcock release statement on FDA's new report about root causes and solutions to drug shortages.10.30.19
-
CPhI Annual Report 2019: Part 1
FDA should withdraw ANDAs, and new technologies could bring massive improvements in efficiency if implemented correctly.10.29.19
-
The Role of Technology Within Regulatory Compliance in Bioanalysis
Learn how current technology is playing a role in the regulatory process at PharmSci 36010.29.19
-
Clinical Trial Materials | Clinical Trials | Information Technology
Contract Pharma’s 20th Anniversary Series: Clinical Supply
Technology plays a big role in clinical trials, supplies, and the rise of patient-centricityKristin Brooks, Contract Pharma 10.29.19
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
Contract Pharma’s 20th Anniversary Series: CRO Perspective
Randy Marchbanks of PPD discusses how CRO operations have evolved to accommodate changing industry needsKristin Brooks, Contract Pharma 10.28.19
-
-
-
Breaking News | Capsules | Facilities | Industry News
CDMO to Invest Over €3M in GMP Facility Expansion
Micro-Sphere will add an additional spray drying line to its facility in Switzerland.10.28.19
-
Breaking News | Facilities | Industry News | Inspections
WuXi STA’s Jinshan Facility Passes EMA Inspection
Five-day inspection covered 11 products approved by EMA in recent years.10.28.19
-
Clinical Trials | Information Technology
Clinical Trial Technology
The use of new technology to monitor and manage clinical trials.Ricky Lakhani, Director of Product Management, PHARMASEAL 10.25.19
-
Breaking News | Packaging & Tracking | Serialization | Supply Chain
Barcode Assessment Study Reveals Progress Addressing DSCSA Requirements
GS1 US Barcode Assessment Shows 74% of scanned barcodes meet serialization requirements.10.24.19